Search
Search Results
##search.searchResults.foundPlural##
-
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7353PDF: 2385HTML: 1713Table 1.: 190Table 2.: 204Table 3.: 185Table 4.: 183 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3338PDF: 1272HTML: 1853Fig.1: 187Fig. 2: 194 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1261HTML: 290PDF: 915Suppl. Files: 437 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1804HTML: 1401PDF: 1053 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2549PDF: 1584HTML: 2344Table1: 181 -
-
POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia
461PDF: 230HTML: 33 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1338PDF: 851HTML: 7924Untitled: 192 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4007PDF: 1124HTML: 1923Fig.1: 209Fig. 2: 104Table 1: 192Table2: 206Table 3: 186 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
2846PDF: 1311HTML: 150 -
IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?
1291PDF: 808HTML: 2894cover leer: 136 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
891PDF: 1054Suppl. Files: 134HTML: 64 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
946PDF: 598HTML: 216 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2147PDF: 1177HTML: 3698 -
-
WHAT ARE FUNGAL INFECTIONS?
4096PDF: 2337HTML: 27565de Pauw: 223 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3254PDF: 1440HTML: 3993 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4271PDF: 1466HTML: 1536Untitled: 212 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1987PDF: 781HTML: 1030 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3276PDF: 568HTML: 640 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2358PDF: 838HTML: 2445 -
SOLITARY PLASMACYTOMA
3792PDF: 2152HTML: 1207fIGURES 1,2: 197 -
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1991PDF: 803HTML: 203 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2657PDF: 987HTML: 2243 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
887PDF: 474Html: 135Suppl. Files: 166 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2850PDF: 1335HTML: 3556Untitled: 181Untitled: 190Untitled: 167







